Springer Nature
Browse
13046_2018_999_MOESM1_ESM.docx (15.39 kB)

Additional file 1: of Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer

Download (15.39 kB)
journal contribution
posted on 2019-01-11, 05:00 authored by Elaine Reguera-NuĂąez, Ping Xu, Annabelle Chow, Shan Man, Frank Hilberg, Robert Kerbel
Table S1. Phase II and III Clinical trials evaluating Atezolizumab in combination with Bevacizumab (DOCX 15 kb)

Funding

Canadian Institutes of Health Research

History

Usage metrics

    Journal of Experimental & Clinical Cancer Research

    Categories

    Keywords

    VEGFAntiangiogenic drugsChemotherapyImmune checkpoint therapyPD-L1MetastasisPreclinical models

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC